2021
Patient-centric decision framework for treatment alterations in patients with Chemotherapy-induced Peripheral Neuropathy (CIPN)
Hertz DL, Childs DS, Park SB, Faithfull S, Ke Y, Ali NT, McGlown SM, Chan A, Grech LB, Loprinzi CL, Ruddy KJ, Lustberg M. Patient-centric decision framework for treatment alterations in patients with Chemotherapy-induced Peripheral Neuropathy (CIPN). Cancer Treatment Reviews 2021, 99: 102241. PMID: 34174668, DOI: 10.1016/j.ctrv.2021.102241.Peer-Reviewed Original ResearchConceptsChemotherapy-induced peripheral neuropathyNeurotoxic chemotherapy treatmentTreatment alterationsCIPN severityPeripheral neuropathyPatient factorsChemotherapy treatmentRelative dose intensityClinical Oncology guidelinesNeurotoxic chemotherapyDose intensityProspective trialOncology guidelinesRetrospective analysisAdult cancersIndividual patientsInconsistent recommendationsPatientsTreatment efficacyClinical decisionSeverityNeuropathyAmerican SocietyTreatmentClinicians
2013
Integrative model for breast cancer survivorship.
Reinbolt R, Shapiro C, Garrett J, Basinger H, Lester J, Muscari N, Ries K, Lustberg M. Integrative model for breast cancer survivorship. Journal Of Clinical Oncology 2013, 31: 132-132. DOI: 10.1200/jco.2013.31.26_suppl.132.Peer-Reviewed Original ResearchElectronic medical recordsIntegrative care modelCare plansMedical recordsCare modelCancer survivorship care planningSurvivorship care planningIndividualized care plansBreast cancer survivorshipCross-sectional studyGroup educational sessionsEarly survivorshipBetter address needsSmart phrasesMedical oncologistsPrimary nurseTreatment summaryDistress ThermometerIndividual patientsCancer survivorshipNurse practitionersCare planningBreast programPhysical symptomsPatients